Dr. Kujtan on Patient Preferences in the Treatment of NSCLC
January 23rd 2019Lara Kujtan, MD, assistant professor at the University of Missouri–Kansas City School of Medicine, discusses the importance of patient preferences in the treatment of oncogene-driven non-small cell lung cancer (NSCLC).
Read More